Related Experiment Video
Updated: May 16, 2026
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
The role of molecular testing in the diagnosis of cutaneous soft tissue tumors
Alison L Cheah1, Steven D Billings
1Department of Anatomic Pathology, Cleveland Clinic, L25, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Abstract:
A number of soft tissue tumors are characterized by recurring genetic abnormalities. The identification of these abnormalities has advanced our understanding of the biology of these tumors and has led to the development of molecular tests that are helpful diagnostically. This review will focus on the application of molecular diagnostic testing in select mesenchymal tumors of the dermis and subcutis.
Insights
Recurring genetic abnormalities in soft tissue tumors aid diagnosis. Molecular tests, based on these findings, improve the diagnostic accuracy for mesenchymal tumors of the dermis and subcutis.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Soft tissue tumors frequently exhibit recurrent genetic abnormalities.
- Understanding these genetic alterations enhances tumor biology insights.
- This knowledge facilitates the development of diagnostic molecular tests.
Purpose of the Study:
- To review the application of molecular diagnostic testing.
- Focus on select mesenchymal tumors of the dermis and subcutis.
- Highlight the diagnostic utility of molecular findings.
Main Methods:
- Review of scientific literature.
- Analysis of genetic abnormalities in soft tissue tumors.
- Evaluation of molecular diagnostic test applications.
Main Results:
- Genetic abnormalities are key identifiers in soft tissue tumors.
- Molecular tests offer significant diagnostic value.
- Specific mesenchymal tumors benefit from targeted molecular diagnostics.
Conclusions:
- Molecular diagnostics are crucial for soft tissue tumor classification.
- Genetic profiling improves diagnostic precision.
- Further application in dermal and subcutaneous mesenchymal tumors is warranted.
